Biotech news
Americas
Resolving complex legal disputes and explaining technical concepts in a courtroom are all part of the job for Regeneron’s Larry Coury, who talks to LSIPR about life as senior director of dispute resolution. 10 November 2017
Americas
Finding therapies that are safe, effective and available requires hard work and putting patients first, according to Daniela Verthelyi of the FDA, who discusses her role as chief of the immunology laboratory at the government agency. 10 November 2017
Pharma
From the Unified Patent Court to life sciences industrial strategy, there are many issues for Sean Dennehey to contend with as deputy CEO of the UK Intellectual Property Office. He talks to LSIPR about how he managed. 10 November 2017
Biotech
As CEO of the UK BioIndustry Association, Steve Bates works closely with industry and government and, by 2025, he wants the UK to become home to the third biggest global biotech cluster, as he explains to LSIPR. 10 November 2017
Americas
Jennifer Doudna was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports. 10 November 2017
Americas
Feng Zhang was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 10 November 2017
Americas
Debra Liebert was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports. 10 November 2017
Biotech
Sven Lingjaerde was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Biotech
Denis Lucquin was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Americas
Robert Nelsen was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017